Halaven® (eribulin) listed on the Pharmaceutical Benefits Scheme for patients with previously treated, advanced liposarcoma
Australian patients suffering from advanced liposarcoma, previously treated with chemotherapy, will now have access to…
Browsing: Rare Cancers
Promising new treatment for rare pregnancy cancer leads to remission in patients
An immunotherapy drug can be used to cure women of a rare type of cancer…
COSA 2017: How do we improve cancer care?
Professor Dorothy Keefe, from the University of Adelaide, presented at the Clinical Oncology Society of…
Liquid biopsy spots aggressive paediatric brainstem cancer earlier without surgery
A particularly aggressive form of paediatric cancer can be spotted reliably by the genetic fragments…
For cancer patients with HIV, immunotherapy appears safe
A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many…
Researchers show the potential of precision medicine for treating rare cancers
For the first time, researchers have been able to identify effective treatments for patients with…
How we can overcome the lack of treatment options for rare cancers
Colman Taylor, University of Sydney and John Zalcberg, Monash University Rare cancers are just that:…
ESMO 2017: DNA Sequencing Could Open Up New Drug Indications for Patients with Rare Cancers
Thanks to DNA sequencing, patients with rare cancers for which no standard treatment is available…
New mutations related to hereditary neuroendocrine tumours
Pheochromocytomas and paragangliomas are rare neuroendocrine tumours with a strong hereditary component. Half the genes…
New epigenomic strategies in the clinical management of cancer of unknown primary
The invention of the EPICUP epigenetic test last year allowed physicians to elucidate what type…